News & Events about Cti Biopharma Corp.
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SEATTLE, March 20, 2023 SEATTLE, March 20, 2023 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC), a commercial...
StockNews.com upgraded shares of CTI BioPharma (NASDAQ:CTIC Get Rating) from a sell rating to a hold rating in a research report released on Tuesday . Several other equities analysts also recently issued reports on the stock. JMP Securities reissued a market outperform rating and set a $9.00 price ...
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SEATTLE, Feb. 7, 2023 SEATTLE, Feb. 7, 2023 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an authorized...
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SEATTLE, Jan. 24, 2023 SEATTLE, Jan. 24, 2023 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that an...
Research and Development of Advanced Therapeutics for Ovarian Cancer Fueling Hope Research and Development of Advanced Therapeutics for Ovarian Cancer Fueling Hope PR Newswire PALM BEACH, Fla., Dec. 1, 2022 FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Dec. 1, 2022 /PRNewswire/ -- The...